Akorn ROA 2006-2018 | AKRX

Current and historical return on assets (ROA) values for Akorn (AKRX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $0.841B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $58.248B 10.24
Teva Pharmaceutical Industries (TEVA) Israel $23.317B 6.10
Mylan (MYL) United Kingdom $18.315B 7.74
Dr Reddy's Laboratories (RDY) India $4.918B 29.37
Supernus Pharmaceuticals (SUPN) United States $2.842B 35.63
AxoGen (AXGN) United States $1.901B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.800B 3.03
Assembly Biosciences (ASMB) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.805B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.788B 73.48
Adamas Pharmaceuticals (ADMS) United States $0.731B 0.00
CymaBay Therapeutics (CBAY) United States $0.729B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.609B 0.00
Voyager Therapeutics (VYGR) United States $0.604B 0.00
Corium (CORI) United States $0.286B 0.00
Teligent (TLGT) United States $0.226B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.107B 0.00
Versartis (VSAR) United States $0.073B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.071B 0.00
Aevi Genomic Medicine (GNMX) United States $0.056B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.030B 0.00
Acasti Pharma (ACST) Canada $0.021B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00